G6416

GW5074

powder

• Synonim(y): 3-(3,5-Dibromo-4-hydroxybenzyliden)-5-iodo-1,3-dihydroindol-2-one
• Wzór empiryczny (zapis Hilla): C₁₅H₈Br₂INO₂
• Numer CAS: 220904-83-6
• Masa cząsteczkowa: 520.94
• NACRES: NA.77
• PubChem Substance ID: 24278455
• UNSPSC Code: 12352200
• MDL number: MFCD03453076
• Assay: ≥98% (HPLC)
• Form: powder
• Quality level: 100
• Storage condition: protect from light

Właściwości

• assay: ≥98% (HPLC)
• Quality Level: 100
• form: powder
• storage condition: protect from light
• color: yellow to orange-brown
• solubility: DMSO: 5 mg/mL, clear
• storage temp.: room temp
• SMILES string: Oc1c(Br)cc(cc1Br)\C=C2/C(=O)Nc3ccc(I)cc23
• InChI: 1S/C15H8Br2INO2/c16-11-4-7(5-12(17)14(11)20)3-10-9-6-8(18)1-2-13(9)19-15(10)21/h1-6,20H,(H,19,21)/b10-3-
• InChI key: LMXYVLFTZRPNRV-KMKOMSMNSA-N
• Gene Information: human ... RAF1(5894)

Opis

Application

GW5074 has been used as a specific inhibitor of cRaf1 in C2 murine skeletal myoblasts, HT-29 colorectal adenocarcinoma cell line and neutrophils.

Biochem/physiol Actions

GW5074 is a cRaf1 kinase inhibitor, which is placed immediately downstream of Ras in the Motogen activated protein kinase (MAPK) signaling pathway. It elicits protection in GW5074 prevents degeneration in Huntington′s disease and also have therapeutic potential in treating neurodegenerative disorders. GW5074 in combination with anti-inflammatory drug, dexamethasone, attenuates sidestream smoke-induced airway inflammation.

Other Notes

light sensitive

Legal Information

Sold for research purposes under agreement from Glaxo­Smith­Kline

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• Klasa składowania: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable
• ppe: Eyeshields, Gloves, type N95 (US)